Opinion

Video

Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
Glaucoma, Cholesterol, Lipid | Image Credit: © Saiful52 | stock.adobe.com
January 14th 2025

Data Show Dyslipidemia as Independent Risk Factor for Primary Open-Angle Glaucoma

Ashley Gallagher, Editor
Triglyceride, Density Lipoprotein Cholesterol, MACE, Major Cardiovascular Events | Image Credit: © jarun011 | stock.adobe.com
January 8th 2025

Investigators Find Triglyceride/High Density Lipoprotein Cholesterol Ratio Is Significantly Associated With MACE

Ashley Gallagher, Editor
Lipoproteins | Image Credit: © chayantorn - stock.adobe.com
December 27th 2024

KRAKEN Trial Highlights Muvalaplin’s Efficacy, Safety in Reducing Lipoprotein(a)

Alexandra Gerlach, Associate Editor
Gut microbiota under magnifying glass | Image Credit: © Scott - stock.adobe.com
December 26th 2024

Cholesterol-Metabolizing Bacteria May Potentially Benefit Lipid Homeostasis, Cardiovascular Health

Alexandra Gerlach, Associate Editor
HDL and LDL molecules | Image Credit: © Ratchada - stock.adobe.com
December 19th 2024

FDA Receive a Biologic License Application for Lerodalcibep, a Novel LDL-C-Lowering Drug

Alexandra Gerlach, Associate Editor
Researchers Raise Questions About Low-Carb Diets and Effects on LDL Cholesterol
December 16th 2024

Researchers Raise Questions About Low-Carb Diets and Effects on LDL Cholesterol

Sabina Alikhanov Palmieri, PharmD